Press Releases

Green Flower Teams with New Florida University Partner to Offer Online Cannabis Certificate Programs

VENTURA, Calif., Oct. 8, 2020 /PRNewswire/ — Green Flower, the world’s leading education provider for cannabis, announced the inaugural launch of professionally developed, non-credit certificate programs in partnership with Florida Atlantic University Center for Online and Continuing Education, their seventh university partner. The innovative, six-month programs prepare professionals to fill the growing skills gap in the legalized cannabis industry.


Curaleaf Announces Upcoming Investor Conference Participation

WAKEFIELD, Mass., Sept. 28, 2020 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, today announced management is scheduled to participate in the following upcoming investor conference events:


Legalization Efforts Continue to Drive the Cannabis Market Growth

NEW YORK, Sept. 25, 2020 /PRNewswire/ — The legalization of cannabis in several countries is one of the key factors driving the market’s growth. In addition, the use of cannabis for medical purposes is gaining momentum worldwide. Medical cannabis products are used for the treatment of various chronic conditions such as cancer, arthritis, and neurological conditions, as well as anxiety, depression, epilepsy, as well as Parkinson’s and Alzheimer’s disease. This year, the elections across the country will help determine the future of cannabis products in several states and could have an influence on the federal legalization in the future. According to Leafy, six states will be voting on legalization this November, with four states are voting on adult-use (recreational) cannabis legalization: Arizona, Montana, New Jersey, and South Dakota. Two states are voting on medical marijuana legalization: Mississippi, and South Dakota. Oregon voters will consider two separate drug reform measures. One would legalize the medical use of psilocybin. The other would decriminalize small amounts of all drugs. MediPharm Labs Corp. (OTC: MEDIF) (TSX: LABS), HEXO Corp. (NYSE: HEXO), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), OrganiGram Holdings Inc. (OGI), GW Pharmaceuticals plc (NASDAQ: GWPH)



Akerna

Akerna Corp. Announces Fourth Quarter Fiscal Year 2020 Earnings Release and Conference Call Information

DENVER, Sept. 17, 2020 /PRNewswire/ — Akerna (Nasdaq: KERN), an enterprise software, leading compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), will report financial results for its fourth quarter and fiscal year ended June 30, 2020 on Thursday September 24, 2020. Akerna will host a conference call at 8:30am Eastern Time on the same day to discuss its financial results and business highlights. A question and answer session will follow prepared remarks.






Canopy Rivers Announces Receipt of Statement of Claim in Respect of Pharmhouse Joint Venture

TORONTO, Sept. 14, 2020 /PRNewswire/ – Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) announced that it has received a statement of claim (the “Claim”) filed by 2615975 Ontario Inc., the Company’s joint venture partner in PharmHouse Inc. (“PharmHouse”), concerning certain disputes relating to PharmHouse. The Claim makes a number of allegations against the Company, Canopy Growth Corporation (“Canopy Growth“), and TerrAscend Corp. and TerrAscend Canada Inc. (together, “TerrAscend”), including claims relating to bad faith, fraud, civil conspiracy, breach of the duty of honesty and good faith in contractual relations and breach of fiduciary duty, and claims relating to PharmHouse’s offtake agreements with Canopy Growth and TerrAscend.